Fortress Biotech
FBIO
#9547
Rank
A$73.36 M
Marketcap
$2.48
Share price
4.25%
Change (1 day)
-8.40%
Change (1 year)

Operating Margin for Fortress Biotech (FBIO)

Operating Margin as of April 2025 (TTM): -208.84%

According to Fortress Biotech 's latest financial reports and stock price the company's current Operating Margin is -208.84%. At the end of 2023 the company had an Operating Margin of -181.79%.

Operating Margin history for Fortress Biotech from 2016 to 2024

Operating Margin at the end of each year

Year Operating Margin Change
2023-181.79%-35.5%
2022-281.83%17.96%
2021-238.92%5.93%
2020-225.55%-18.73%
2019-277.54%-42.96%
2018-486.57%-13.95%
2017-565.46%30.72%
2016-432.58%-93.07%
2015-6,243.68%

Operating Margin for similar companies or competitors

Company Operating Margin Operating Margin differencediff. Country
-399,877.00% 191,375.29%๐Ÿ‡บ๐Ÿ‡ธ USA
5.77%-102.76%๐Ÿ‡บ๐Ÿ‡ธ USA
-61.01%-70.79%๐Ÿ‡บ๐Ÿ‡ธ USA
11.12%-105.32%๐Ÿ‡บ๐Ÿ‡ธ USA

What is a company's Operating Margin?

The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.